The immunohistochemical expression of STAT3, Bcl-xL, and MMP-2 proteins in colon adenoma and adenocarcinoma

Gut and Liver

Volumn 6, Issue 1, 2012, Pages 45-51

  Lee, Seung Woo ^a   Ahn, Young Yong ^a   Kim, Yon Soo ^a   Kang, Sang Beum ^a   Nam, Soon Woo ^a   Lee, Dong Soo ^a   Jeong, Hyun Yong ^a   Kim, Jin Man ^b  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b Chungnam National University College of Medicine   (South Korea)

Author keywords

B cell lymphoma extra large; Colon; Matrix metalloproteinase 2; Signal transducers and activators of transcription 3

Indexed keywords

GELATINASE A; PROTEIN BCL XL; STAT3 PROTEIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; COLON ADENOMA; COLON CARCINOMA; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; TUMOR VOLUME;

EID: 84862928203     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2012.6.1.45     Document Type: Article

References (45)

1. Shike M, Winawer SJ, Greenwald PH, Bloch A, Hill MJ, Swaroop SV. Primary prevention of colorectal cancer. The WHO Collaborating Centre for the Prevention of Colorectal Cancer. Bull World Health Organ 1990;68:377-385.
2. Jackman RJ, Mayo CW. The adenoma-carcinoma sequence in cancer of the colon. Surg Gynecol Obstet 1951;93:327-330.
3. Bromberg J. Stat proteins and oncogenesis. J Clin Invest 2002;109:1139-1142. (Pubitemid 34496590)
4. Darnell JE Jr. STATs and gene regulation. Science 1997;277:1630-1635.
5. Huang S. Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications. Clin Cancer Res 2007;13:1362-1366. (Pubitemid 46450423)
6. Levy DE, Darnell JE Jr. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 2002;3:651-662. (Pubitemid 34987786)
7. Mora LB, Buettner R, Seigne J, et al. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. Cancer Res 2002;62:6659-6666. (Pubitemid 35364135)
8. Smithgall TE, Briggs SD, Schreiner S, Lerner EC, Cheng H, Wilson MB. Control of myeloid differentiation and survival by Stats. Oncogene 2000;19:2612-2618. (Pubitemid 30339217)
9. Huang M, Page C, Reynolds RK, Lin J. Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells. Gynecol Oncol 2000;79:67-73.
10. Xie TX, Huang FJ, Aldape KD, et al. Activation of stat3 in human melanoma promotes brain metastasis. Cancer Res 2006;66:3188-3196.
11. Boise LH, Gonzalez-Garcia M, Postema CE, et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993;74:597-608. (Pubitemid 23259741)
12. Tsujimoto Y, Shimizu S. Bcl-2 family: life-or-death switch. FEBS Lett 2000;466:6-10. (Pubitemid 30050673)
13. Vander Heiden MG, Chandel NS, Williamson EK, Schumacker PT, Thompson CB. Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 1997;91:627-637. (Pubitemid 27513654)
14. Gottlieb E, Vander Heiden MG, Thompson CB. Bcl-x(L) prevents the initial decrease in mitochondrial membrane potential and subsequent reactive oxygen species production during tumor necrosis factor alpha-induced apoptosis. Mol Cell Biol 2000;20:5680-5689. (Pubitemid 30482901)
15. Lynch CC, Matrisian LM. Matrix metalloproteinases in tumor-host cell communication. Differentiation 2002;70:561-573. (Pubitemid 36194320)
16. Poulsom R, Pignatelli M, Stetler-Stevenson WG, et al. Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol 1992;141:389-396.
17. Zucker S, Vacirca J. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev 2004;23:101-117. (Pubitemid 38221598)
18. Jass JR, Sobin LH, Morson BC. Histological typing of intestinal tumours. New York: Springer-Verlag, 1989.
19. Greene FL; American Joint Committee on Cancer. AJCC cancer staging handbook: TNM classification of malignant tumors. New York: Springer, 2002.
20. Wegenka UM, Buschmann J, Lutticken C, Heinrich PC, Horn F. Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol Cell Biol 1993;13:276-288. (Pubitemid 23006905)
21. Yu H, Jove R. The STATs of cancer: new molecular targets come of age. Nat Rev Cancer 2004;4:97-105. (Pubitemid 38198738)
22. Spiekermann K, Biethahn S, Wilde S, Hiddemann W, Alves F. Constitutive activation of STAT transcription factors in acute myelogenous leukemia. Eur J Haematol 2001;67:63-71. (Pubitemid 33010380)
23. Garcia R, Bowman TL, Niu G, et al. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 2001;20:2499-2513. (Pubitemid 32531347)
24. Dhir R, Ni Z, Lou W, DeMiguel F, Grandis JR, Gao AC. Stat3 activation in prostatic carcinomas. Prostate 2002;51:241-246. (Pubitemid 34556374)
25. Catlett-Falcone R, Landowski TH, Oshiro MM, et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 1999;10:105-115. (Pubitemid 29077388)
26. Ma XT, Wang S, Ye YJ, Du RY, Cui ZR, Somsouk M. Constitutive activation of Stat3 signaling pathway in human colorectal carcinoma. World J Gastroenterol 2004;10:1569-1573. (Pubitemid 38786933)
27. Kusaba T, Nakayama T, Yamazumi K, et al. Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma: correlation with clinicopathological factors. J Clin Pathol 2005;58:833-838. (Pubitemid 41113390)
28. Liu L, McBride KM, Reich NC. STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-alpha3. Proc Natl Acad Sci U S A 2005;102:8150-8155. (Pubitemid 40800058)
29. Yang J, Chatterjee-Kishore M, Staugaitis SM, et al. Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation. Cancer Res 2005;65:939-947. (Pubitemid 40216455)
30. Liddle FJ, Alvarez JV, Poli V, Frank DA. Tyrosine phosphorylation is required for functional activation of disulfide-containing constitutively active STAT mutants. Biochemistry 2006;45:5599-5605. (Pubitemid 43673190)
31. Bromberg JF, Wrzeszczynska MH, Devgan G, et al. Stat3 as an oncogene. Cell 1999;98:295-303. (Pubitemid 29380565)
32. Xie TX, Wei D, Liu M, et al. Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene 2004;23:3550-3560. (Pubitemid 38658421)
33. Horiguchi A, Oya M, Shimada T, Uchida A, Marumo K, Murai M. Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome. J Urol 2002;168:762-765. (Pubitemid 34793359)
34. Reed JC, Miyashita T, Takayama S, et al. BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J Cell Biochem 1996;60:23-32. (Pubitemid 26047917)
35. McDonnell TJ, Beham A, Sarkiss M, Andersen MM, Lo P. Importance of the Bcl-2 family in cell death regulation. Experientia 1996;52:1008-1017. (Pubitemid 26379183)
36. Lee DS, Kang SB, Baek JT, et al. Immunohistochemical expression of bcl-2, bcl-xL, bax, p53 proteins in gastric adenoma and adenocarcinoma. Korean J Gastroenterol 2005;45:394-400.
37. Krajewska M, Moss SF, Krajewski S, Song K, Holt PR, Reed JC. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Res 1996;56:2422-2427. (Pubitemid 26154093)
38. Friess H, Lu Z, Andren-Sandberg A, et al. Moderate activation of the apoptosis inhibitor bcl-xL worsens the prognosis in pancreatic cancer. Ann Surg 1998;228:780-787. (Pubitemid 30191689)
39. Zhang YL, Pang LQ, Wu Y, Wang XY, Wang CQ, Fan Y. Significance of Bcl-xL in human colon carcinoma. World J Gastroenterol 2008;14:3069-3073.
40. Kusaba T, Nakayama T, Yamazumi K, et al. Activation of STAT3 is a marker of poor prognosis in human colorectal cancer. Oncol Rep 2006;15:1445-1451.
41. Tsareva SA, Moriggl R, Corvinus FM, et al. Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction. Neoplasia 2007;9:279-291. (Pubitemid 46608295)
42. Tomita T, Iwata K. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in colonic adenomas-adenocarcinomas. Dis Colon Rectum 1996;39:1255-1264. (Pubitemid 26389536)
43. Parsons SL, Watson SA, Collins HM, Griffin NR, Clarke PA, Steele RJ. Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy. Br J Cancer 1998;78:1495-1502. (Pubitemid 28517547)
44. Shin JE, Jung SA, Kim SE, et al. Expression of MMP-2, HIF-1alpha and VEGF in colon adenoma and colon cancer. Korean J Gastroenterol 2007;50:9-18.
45. Mysliwiec AG, Ornstein DL. Matrix metalloproteinases in colorectal cancer. Clin Colorectal Cancer 2002;1:208-219. (Pubitemid 34269381)